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Abstract
Dementia poses major public health challenges, and high-
quality epidemiological data are needed for service plan-
ning. Published estimates of numbers of people with de-
mentia in Portugal have been based, in most cases, on prev-
alence rates derived from international studies or expert 
consensus. As in many other countries, Portuguese commu-
nity prevalence studies’ results are nongeneralizable to a 
country level. Moreover, their prevalence estimates differ 
(not surprisingly, owing to different methodologies, e.g., de-
sign, sampling, and diagnostic criteria). Regardless, the Por-
tuguese 10/66 Dementia Research Group (10/66 DRG) pop-
ulation-based survey fulfilled 10 out of 11 Alzheimer’s Dis-
ease International quality criteria for prevalence studies. It 
relied on cross-culturally validated methods, fostering a 
wide comparability of results. Therefore, we can provide 
rough estimates of 217,549 community dwellers with de-
mentia in Portugal according to the 10/66 DRG criteria (that 
would be only 85,162 according to DSM-IV criteria). This re-
fers to people aged 65 years or older who are not institution-
alized. Although broadly consistent with international pro-
jections, these estimates must be cautiously interpreted. 
Particularly in the context of scarce funding, which will prob-
ably last for years, we need more efficient, evidence-based 
dementia policies. Concerning further epidemiological stud-
ies, high-quality methods are needed but also their compa-
rability potential should be improved at national and inter-
national levels. Most of all, fund allocation in Portugal should 
now privilege routine dementia information systems in both 
health and social services.
© 2021 The Author(s). Published by S. Karger AG, Basel
on behalf of NOVA National School of Public Health
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Resumo
As demências são um grave problema de saúde pública e 
os serviços deveriam ser planeados tendo em conta o co-
nhecimento epidemiológico. As estimativas publicadas 
quanto ao número de pessoas com demência em Portugal 
têm sido baseadas, maioritariamente, nos resultados in-
ternacionais de estudos de prevalência ou consensos de 
peritos. Os resultados dos estudos de campo portugueses 
sobre prevalência das demências diferem (o que não é sur-
preendente, dadas as discrepâncias metodológicas em 
termos de desenho, amostragem ou critérios diagnósti-
cos). Tal como em muitos outros países, estes resultados 
não são generalizáveis a nível nacional. Todavia, o estudo 
populacional realizado em Portugal com a metodologia 
do ‘10/66 Dementia Research Group’ (10/66 DRG) alcan-
çou um número elevado de critérios de qualidade ADI - Al-
zheimer’s Disease International para estudos de prevalên-
cia (10 em 11). Como se baseou em métodos validados 
transculturamente, os seus resultados prestam-se a com-
parações internacionais. Permitem estimar em cerca de 
217,549 as pessoas mais velhas com demência, residindo 
na comunidade, em Portugal (pelo algoritmo de diag-
nóstico 10/66 DRG), embora apenas 85,162 pelos critérios 
DSM-IV. Sendo genericamente concordantes com dados 
internacionais, estas projecções circunscrevem-se a pes-
soas não institucionalizadas e devem ser interpretadas 
prudentemente. Sobretudo perante constrangimentos fi-
nanceiros globais e previsivelmente duradouros, também 
na área da demência se impõem políticas com base cientí-
fica e eficientes. Futuros estudos epidemiológicos deveri-
am assegurar, a par da qualidade metodológica, a compa-
rabilidade de resultados, a nível nacional e internacional. 
Nos tempos mais próximos, defendemos o foco na melho-
ria dos sistemas de informação sobre demência em Portu-
gal, ao nível dos serviços de saúde e sociais.
© 2021 The Author(s). Published by S. Karger AG, Basel
on behalf of NOVA National School of Public Health
Service Planning Should Rely on Epidemiological 
Evidence
Dementia is a public health issue worldwide, with a 
heavy burden of disease and impact on families and in-
formal caregivers [1–3]. In Portugal, official policies have 
been lacking for decades [4, 5], but efforts were recently 
made toward a national dementia strategy [6, 7]. 
Efficient dementia prevention and care delivery call 
for the implementation of an integrated health and social 
services framework. A robust evidence base is needed [5], 
and international reports advise regular updating of epi-
demiological data [1, 8]. Recently, high-quality research 
was conducted in low- and middle-income countries [9], 
whereas in more industrialized regions, where most clas-
sic prevalence studies have taken place, we run the risk of 
becoming outdated. In Europe, epidemiological surveys 
are nowadays difficult to implement, owing to financial 
constraints and low participation. This applies not only 
to costly incidence studies but also to prevalence ones. 
Although epidemiological fieldwork studies were in-
existent in Portugal until recently, important evidence on 
the community prevalence of dementia is now available. 
Regardless, 2 issues remain. First, published Portuguese 
estimates of numbers of people with dementia have not 
considered evidence directly stemming from population-
al fieldwork. Second, should we use findings derived from 
national samples to estimate those numbers, the results of 
Portuguese community prevalence studies will differ to a 
considerable extent. The question remains: why do they 
differ? In this paper, we aim to address these issues, con-
tributing to the discussion of dementia policies and ser-
vice planning in Portugal. Mild cognitive disorders are 
beyond our aim despite their importance as a risk factor 
for dementia in up to a fifth of older-age people and the 
need for adequate interventions [8]. Instead, we chose to 
focus on cognitive decline with consequent social or oc-
cupational impairment, i.e., dementia. 
Published Counts of People with Dementia in Portugal
Until recently, Portuguese authors were restricted to 
indirect methods to estimate the number of people with 
dementia in the Country. These extrapolations relied on 
international prevalence rates or expert consensus. A first 
one [10] was published in 1994, based on EURODEM 
study results; Garcia et al. estimated 92,470 persons in the 
general population, 48,706 of them with Alzheimer dis-
ease (AD). The EuroCODE consortium provided an up-
dated number of 153,000 in 2008 [11] and Alzheimer Eu-
rope reported 182,526 people with dementia aged 60+ 
years in 2013 [12]. Santana et al. [13] then used the 2005 
Delphi consensus rates for the EURO A region [14] to 
estimate 160,287 people with dementia aged 60 years or 
older by 2014, as well as 80,144–112,201 people with AD. 
Others [15] calculated 187,052 in 2020, based again on the 
Global Prevalence of Dementia consensus [14].
Despite their usefulness, there are obvious caveats with 
such extrapolations. Paraphrasing Ferri et al. [14]: reliabil-
ity of international consensus estimates does not ensure 
validity, particularly regarding regions with fewer popula-
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tional studies and even if they have originated in countries 
with sociocultural similarities. None of these calculations 
built on Portuguese fieldwork, and the inclusion or not of 
nursing home (NH) residents was not entirely clear. Now 
that community prevalence studies – their own limita-
tions notwithstanding – are available, an update is needed. 
In fact, a 2019 policy report by Alzheimer Europe es-
timated the total number of people with dementia in Eu-
rope and additionally extrapolated per country. Regard-
ing Portugal, this report differed from those mentioned 
above in that it used raw data combined from studies of 
national samples [16–18]; 193,516 people living with de-
mentia in the community were estimated [19]. However, 
the authors did not meta-analyze the national results and 
it should be highlighted that the 3 studies considered are 
different in nature (Table 1); pooling their results to pro-
duce a single count might oversimplify complex matters. 
That is why we would now like to discuss the rationale for 
using our results alone [17] to produce another estimate.
Portuguese Population-Based Studies Yield 
Different Prevalence Estimates
Population-based prevalence direct estimates of de-
mentia are available for selected catchment areas in Por-
tugal (Table 1).
The first study was conducted in the north [16] in 2 
samples (urban and rural). The prevalence of dementia 
was calculated according to the Diagnostic and Statistical 
Manual of Mental Disorders (DSM)-IV criteria [20] and 
was 2.7% (95% CI 1.9–3.8). A second field survey was 
conducted by our group in the south, also in 2 samples 
(urban and rural) but using the 10/66 Dementia Research 
Group (DRG) method [17, 21]. The 10/66 DRG is an in-
ternational consortium, based at King’s College London, 
whose protocols provide different outputs in terms of de-
mentia case definition not only according to DSM-IV cri-
teria but also according to a regression equation devel-
oped in the 10/66 DRG studies [22]. Concerning the prev-
alence of DSM-IV dementia, the confidence intervals 
overlapped with the study of Nunes et al. [16], i.e., 3.7% 
(95% CI 3.0–5.0). However, the prevalence according to 
the 10/66 algorithm was higher, i.e., 9.2% (95% CI 7.8–
10.9) [17]. A third survey was conducted in Oporto and 
reported a 1.3% estimate for DSM-V dementia preva-
lence [18]. 
Besides discrepancies concerning the proportion of 
dementia subtypes (Table 1), the 3 prevalence estimates 
are different (especially regarding the results of Ruano et 
al. [18], even allowing for their use of the most recent 
DSM version). An obvious question ensues, i.e., what is 
the explanation for these differences? 
Table 1. Three studies on the prevalence of dementia in Portuguese samples: main characteristics and results
Study Nunes et al. [16] The 10/66 DRG study [17] Ruano et al. [18]
Fieldwork dates 2003 2012–2013 2013–2015
Geographical area Urban (S.J. Madeira)  
and rural (Arouca)
Urban (Fernão Ferro, Seixal)  
and rural (Mora, Évora)
Urban (Oporto)
Sampling Random from health
center registries
Population-based (all old-age  
people in the catchment areas)
Population-based  
(representative of Oporto)
Nursing homes? No Not reported No
Age of the participants, years 55–79 ≥65 ≥55
Valid clinical diagnoses of depression/
anxiety?
No (GDS-brief version) Yes (GMS-AGECAT) No (BDI)
Diagnostic criteria for dementia DSM-IV TR DSM-IV and 10/66 DRG DSM-V
Prevalence of dementia 2.7% (95% CI 1.9–3.8) DSM: 3.7% (95% CI 2.8–5.0)
10/66: 9.2% (95% CI 7.8–10.9)
1.0% (no CI presented)a
Dementia subtypes AD (38.7%),
vascular (38.7%)




GDS, Geriatric Depression Scale; BDI, Beck Depression Inventory. a The authors also reported a 1.3% age-standardized prevalence when using both of 
the standard populations of Oporto and Portugal.
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Comparing the Methods of Portuguese Prevalence 
Studies
In Table 2, we display additional characteristics 
(strengths and limitations) of the 3 studies, following the 
Alzheimer’s Disease International (ADI) quality criteria 
for prevalence studies [23] frequently adopted in reviews 
and meta-analyses [1, 24].
Our study used the 10/66 DRG method. In the last 2 
decades, this consortium generated high-quality evidence 
on the epidemiology not only of dementia but also of 
mental health, non-communicable diseases, disability, 
and care dependences [9]. The protocols for prevalence 
surveys were used in many countries (mainly but not only 
low- and middle-oncome countries), impacting on re-
search and public health policies worldwide [9]. 
As detailed elsewhere [17], there were several reasons 
for implementing the 10/66 DRG method in Portugal. 
First, following international recommendations [1, 25], 
we wanted a fixed and fully structured 1-stage, catchment 
area survey, facilitating international comparisons and 
reassessments over time. Despite the economic advantag-
es of classical double-phase designs, 1-phase approaches 
are strongly recommended; there is no attrition bias/in-
formative censoring or need to control for false negatives 
during screening [1, 26]. Second, we were interested in 
comprehensive assessments directed not only at cogni-
tive impairment. Psychiatric disorders are crucial for dif-
ferential diagnosis and their presence may bias estimates 
of dementia-associated disability and burden of disease. 
Late-life depression, in particular, has complex relations 
to dementia; it may be reactive, “homophenotypic”, a 
prodrome, or a risk factor for dementia, or it may just co-
incide [27, 28]. In this area, we should not rely on brief 
rating scales uncritically, especially when cut-off validity 
cannot be taken for granted [29]. Standardized 10/66 
DRG assessments, on the contrary, include, for example, 
an extensive cognitive module, physical examinations, 
detailed informant interviews, and the geriatric mental 
state-automated geriatric examination for computer as-
sisted taxonomy (GMS-AGECAT; a semi-structured in-
terview which is the gold standard in old-age psychiatry 
epidemiological research) [30]. Altogether, the protocol 
provides evidence on dementia diagnoses (DSM-IV, 
Table 2. Three studies on the prevalence of dementia in Portuguese samples: methodological differences according to ADI 2009 criteria
ADI criteriaa Nunes et al. 
[16]
The 10/66  
DRG study
[17]








2-phase study with no sampling of screen negatives Yes Yes
2-phase study, with sampling of screen negatives but no weighting back






Multidomain cognitive test battery Yes Yes Yes
Formal disability assessment Yes Yes No
Informant interview Yes Yes Yes
Clinical interview Yes Yes Yes
Values are presented as numbers unless otherwise stated. a An overall quality score (0–11 points) derived by summing scores for the 
following elements: sample size (<500 = 0.5 points; 500–1,499 = 1 point; 1,500–2,999 = 1.5 points; and >2,999 = 2 points); design (2-phase 
study with no sampling of screen negatives = 0 points; 2-phase study with sampling of screen negatives but no weighing back = 1 point; 
and 1-phase study or 2-phase study with appropriate sampling and weighing = 2); response proportion (<60% = 1 point; 60–79% = 2 
points; and, >79% = 3); and diagnostic assessment (inclusion of a multidomain test battery, a formal disability assessment, an informant 
interview, and a clinical interview = 1 point each).
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ICD-10, and 10/66) and subtypes, mental disorders (“or-
ganicity” – including dementia – depression, anxiety, and 
psychosis), self-reported health conditions and risk fac-
tors, disability/functioning (WHODAS 2.0), and service 
use. Eventually, we were able to assess late-life depression 
(ICD-10 and subsyndromal depression) [31]. Finally, we 
wanted to address concerns that DSM criteria may sys-
tematically underestimate the true dementia prevalence 
in low-education, low-awareness settings. The propor-
tion of old-age people in Portugal is now around 20%, and 
their illiteracy rate is still high [17]. The 10/66 DRG pro-
tocol compares DSM-IV caseness against the 10/66 meth-
od, which has been proven to be fair in terms of culture 
and education, in settings not strikingly different from 
Portuguese rural communities. We acknowledge lacking 
conclusive evidence of the relative validity of the DSM 
and 10/66 DRG approaches in Europe, and the current 
pandemic is delaying our aim of directly establishing the 
validity of the 10/66 DRG criterion. However, the 10/66 
diagnostic algorithm has been extensively validated 
worldwide [9], and our findings support the concurrent 
validation of 10/66 and DSM-IV diagnoses [17].
Therefore, we assessed all individuals aged 65 years or 
older who were residents of mapped catchment areas 
chosen to reflect nationally typical scenarios [17, 21]. Giv-
en the method (design, sampling, and assessment type), 
the response rate (82%), and the analyzable sample size 
(n = 1,405), the overall ADI quality score [23] for the 
study was 10 out of 11 (Table 2). Despite their own limi-
tations [17], these findings provide a better picture of the 
Portuguese reality than estimates based on studies con-
ducted abroad, seldom on nationally representative sam-
ples themselves [32]. Concerning dementia subtypes, 
41.9% of the 10/66 DRG cases were diagnosed with AD 
and 30.2% could not be allocated to pure subtypes [17]. 
Findings were broadly consistent with pooled estimates 
of the AD prevalence in Europe (5.05%; 95% CI 4.73–
5.39) [33].
The studies of Nunes et al. [16] and Ruano et al. [18] 
were similar in that they adopted classical 2-phase designs 
(a screening with cognitive tests followed by detailed clin-
ical assessments of participants screening positive, i.e., 
probable cases). Both relied on the clinical expertise of 
clinicians in the second phase; none reassessed a random 
sample of participants screening negative in the first 
phase, thereby increasing the probability of “false nega-
tives” and making it impossible to weigh back final results 
[1, 34]. As ours, their results were not generalizable be-
yond areas under study and did not target NH, as dis-
cussed below. Discrepancies in dementia subtype preva-
lence estimates are evident, but we would rather focus on 
dementia syndrome diagnosis, as it is more important for 
burden of disease evaluation and service planning.
Although the 3 Portuguese studies’ results are not di-
rectly comparable, they all contribute to our understand-
ing of dementia epidemiology in Portugal, provided their 
Table 3. Number of people with dementia in Portugal according to 10/66 DRG survey prevalence estimates
65–69 years 70–74 years 75–79 years 80+ years Total
Populationa Women 337,447 306,203 250,264 433,167 1,327,081
Men 285,465 243,388 181,794 242,696 953,343
Total 622,912 549,591 432,058 675,863 2,280,424
DSM-IV criteria
Prevalence (95% CI)b Women 0 4.08 (2.05–7.96) 2.89 (1.21–6.77) 7.84 (4.86–12.41)
Men 0.63 (0.09–4.37) 1.29 (0.32–5.02) 5.52 (2.89–10.28) 6.80 (3.69–12.20)
Number of people
with dementia
Women 0 12,493 7,233 33,960 
Men 1,798 3,140 10,035 16,503 
Total 1,798 15,633 17,268 50,463 85,162c
10/66 DRG criteria
Prevalence (95% CI)b Women 0.50 (0.07–3.50) 6.63 (3.89–11.10) 9.83 (6.19–15.26) 19.61 (14.74–25.61)
Men 2.53 (0.96–6.52) 5.81 (3.06–10.75) 11.04 (7.06–16.86) 18.37 (12.89–25.49)
Number of people 
with dementia
Women 1,687 20,301 24,601 84,944 
Men 7,222 14,141 20,070 44,583 
Total 8,909 34,442 44,671 129,527 217,549c
a Latest annual resident population estimates: 2019, from the INE (2020) – https://www.ine.pt/xportal/xmain?xpid=INE&xpgid=ine_indicadores&ind
OcorrCod=0008273&xlang=en. b Prevalence estimates from the first 10/66 DRG survey in Portugal [17]. c This total is based on the sum of age and sex spe-
cific estimates.
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results are discussed taking methodological options into 
account. As the 10/66 DRG study reported 2 alternative 
diagnoses of dementia, and meets most ADI quality cri-
teria, its prevalence estimates may provide an evidence 
base for estimates of people with dementia living in the 
community in Portugal. 
Updated Estimates of People with Dementia 
According to 10/66 DRG Results
Overall, the 10/66 DRG study raises important ques-
tions regarding policies and services. Which diagnostic 
criteria are more appropriate to reflect the community 
burden of dementia: “classical” DSM ones or those of 
the “epidemiological” and clinically validated 10/66? 
Moreover, if we were to rely on the latter, how would 
this shape our estimates of numbers of older people 
with dementia in Portugal today? Let us start with the 
second question and take the first one when discussing 
those numbers.
Estimates regarding Numbers of Community Dwellers 
with Dementia in Portugal
We replicated the method of Santana et al. [13] but 
used age and sex specific prevalence estimates from the 
10/66 DRG study [17] to update numbers for the Portu-
guese older people population in 2019 (2,280,424 resi-
dents), as retrieved from official estimates on June 15, 
2020 [35, 36]. We did not consider the age interval of 60–
64 years, as this category had not been included in our 
field survey. We considered an aggregate age category of 
80 years or older, due to small numbers in our study for 
those in the separate categories 80–84 and 85 years or 
older. 
Table 3 presents a rough estimation of numbers of 
noninstitutionalized older-age people with dementia, in 
Portugal, based on prevalence rates resulting from the 
10/66 DRG study (DSM-IV diagnostic criteria vs. the 
10/66 DRG algorithm) [17]. 
Discussion and Limitations
When we apply the 10/66 DRG dementia prevalence 
estimate, previous projections in Portugal (160, 287 [13] 
to 193,516 [19]) and by the GBD 2016 Dementia Collabo-
rators (166,600; 95% CI 139,562–201,560) [3] are exceed-
ed. Our count (217,549) may even underestimate the total 
number of people with 10/66 dementia as it refers only to 
community dwellers, specifically aged 65 years or older. 
It aligns with the 2015 World Alzheimer Report, with me-
ta-analyzed estimates of dementia prevalence by GBD re-
gion, where the age-standardized prevalence for those 
aged 60 years or older was 6.8% in Western Europe [1]; if 
people in the age category of 60–64 years had been left 
out, this would be even closer to our 9.2% prevalence es-
timate. Our findings are also in line with the 2017 OECD 
analysis of international data, estimating Portuguese peo-
ple with dementia in 20 per 1,000 people in 2017 [37]. The 
same broadly applies to Alzheimer Europe 2019 estimates 
of 193,516, although their extrapolation of a prevalence 
of 1.88% regards the general population. Santana et al. 
[13] used the Global Prevalence of Dementia consensus 
estimates that included institutions [14] and an official 
number of 210,581 fewer Portuguese people aged 65 years 
or older in 2014; this influenced their count in different 
directions, but discrepancies with our results are most 
likely due to different prevalence estimates as the basis for 
calculations.
On the other hand, our lower estimate of 85,162 ac-
cording to the DSM-IV reopens the debate on which 
diagnostic framework better conveys the true commu-
nity burden of dementia, probably undervalued by 
DSM-IV criteria [9, 38]. Despite their high reliability, 
numbers generated based on them probably reflect a 
narrower proportion of more severe cases, failing to 
consider numerous cognitively impaired and disabled 
people who would be typically diagnosed with demen-
tia by clinicians but behave as “false negatives” in sur-
veys. This may be especially so in low- and middle-in-
come countries, rural areas, or low-literacy populations 
due to difficulties in ascertaining cognitive decline and 
its consequences [39], further supporting the 10/66 
DRG approach [17, 21]. Of note, a systematic review 
and meta-analysis reported an age and sex-standard-
ized community prevalence of DSM-IV dementia of 
7.1% in Europe [24]; this is around double of what we 
found in Portugal [17]. Perhaps the inclusion of our 
study in the meta-analysis would lower that estimate, 
probably skewed by some studies restricted to old-old 
participants [24]. In any case, a single focus on DSM-IV 
criteria ignores the direction of travel toward current 
approaches using all available sources of evidence while 
modeling their potential biasing effects. 
We strongly believe that our calculations provide 
sound evidence-based estimates of considerable numbers 
of Portuguese community-dwelling people with demen-
tia. The extrapolation builds on fieldwork meeting ADI 
quality criteria and using structured, transculturally vali-
dated methods to foster international comparability. 
However, this statistical exercise based on a single study 
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is not without limitations. First, the current COVID-19 
pandemic is having a direct impact on the mortality of 
older people, including persons with dementia, which is 
still evolving. Furthermore, we did not include people 
younger than 65 years of age and used prevalence esti-
mates not generalizable at a national level. Most impor-
tantly, these did not include NH residents. Surprisingly, 
previous Portuguese estimates do not explicitly address 
this conundrum.
What about People Living in Institutions?
Gaps in epidemiological evidence regarding NH hin-
der dementia policy making. The prevalence of dementia 
in residential care settings changes from country to coun-
try, depending on funding, eligibility, cultural values and 
norms, the availability of family support, and the propen-
sity of women to work outside the home. It may vary from 
13.4% (Hungary) to 70–80% (Sweden) [40]. However, the 
Alzheimer Europe Yearbook 2017 did not include this 
estimate for Portugal, where many people with moderate 
dementia lack appropriate community services and risk 
precocious institutionalization. In our survey, we did try 
to evaluate NH residents [21] but realized that the low 
number of people who could be legitimately accessed 
with appropriate consent would lead to underestimates of 
the true prevalence. Hence, we decided not to combine 
them with estimates of participants living in the commu-
nity [17]. An overview of our findings is available in the 
online supplementary material (for all online suppl. ma-
terial see www.karger.com/doi/10.1159/000516503). Re-
garding other Portuguese studies, Nunes et al. [16] re-
ported residual cases of institutionalized people with cog-
nitive impairment, and Ruano et al. [18] did not include 
them.
We use the umbrella term NH as roughly equivalent to 
the Portuguese ERPI (Estruturas Residenciais para Pes-
soas Idosas), residential structures for older adults run by 
nonprofit or for-profit private organizations, sometimes 
with state funding. They have some nursing staff support 
and provide higher levels of health and social care than 
“residential houses”, which are rare in Portugal [5]. 
Though generally nonspecific to people with dementia, 
most institutional care for older people is provided by 
them, and some NGO (e.g., Misericórdias) greatly im-
proved their capacity to support frail residents. Around 
3.4% of Portuguese older-age people lived in NH in 2006 
[41], but current estimates are 2,526 ERPI and 99,234 res-
idents in Portugal [42]. These figures do not include nu-
merous illegal institutions, probably accounting for 
around 30.000 residents, or the 4,125 older people sup-
ported by the RNCCI (the national integrated continued 
care network) in long-term and maintenance units in 
2019 [43]. 
Specific estimates of Portuguese NH residents with de-
mentia are very heterogeneous, ranging from 29 to 78% 
[44–48]. The great variability of these findings derives 
from differences in aims and methodologies (design, 
sampling, and assessment tools), but they share their lim-
ited scope. In summary, the clinical characterization (in-
cluding estimation of the dementia prevalence) of Portu-
guese NH has a long way to go.
What Is Next?
Debates on trends in the worldwide incidence and 
prevalence of dementia are ongoing [49]. In high-income 
countries the incidence may be declining, but evidence is 
broadly inconsistent regarding changes in prevalence [50, 
51]. Regardless, population ageing will probably deter-
mine an important increase in numbers of people with 
dementia [37, 50, 52] and Portugal is expected to have one 
of the highest percentages of older people in the world by 
2030 [53]. We should beware of optimistic projections 
regarding this public health problem [50] and focus on 
efficient dementia care policies [5, 54]. 
Implications for Public Policies
WHO and ADI advocate global responses to demen-
tia as a public health priority [2, 55]. In Portugal, this re-
quires design and implementation of a true national de-
mentia plan [5, 6]. Given concerns about the limited im-
plementation of guidelines and programs/plans [56, 57], 
priority choice and feasibility of measures are para-
mount. 
We should avoid multiplying separate programs on 
different old-age health conditions (e.g., diabetes, cardio-
vascular problems, and dementia) and instead gain focus 
by integrating them. Regarding primary prevention, for 
instance, the potential for dementia incidence reduction 
was calculated for Brazil, Mozambique, and Portugal by 
reducing risk factors of dementia over time [58]; these 
included education, vascular risk, and depression [27, 
28]. We could benefit from drawing on recent Integrated 
Care for Older People (ICOPE) guidelines for the man-
agement of decline in intrinsic capacity [59]; these recom-
mendations address decline not only in cognition, but 
also in mobility, nutrition, vision and hearing, and mood 
Counts of People with Dementia in 
Portugal: A Discussion of Estimates
65Port J Public Health 2021;39:58–67
DOI: 10.1159/000516503
and continence, aiming to prevent or delay the onset of 
care dependence and promote healthy ageing. Research, 
including by the 10/66 DRG, supports this framework 
[60].
Another key issue involves primary care services. This 
regards early timely diagnosis of dementia and its appro-
priate disclosure, as well as areas like treatment monitor-
ing, counselling and support, and monitoring of carers’ 
health [5]. Despite international recommendations on 
task sharing with neurologists or psychiatrists, coordina-
tion and continuity of care in truly collaborative environ-
ments is far from being implemented [61].
Implications for Research
On the other hand, assessment of the situation in-
volves not only epidemiologic but also service delivery 
assessments and stakeholder mapping [62]. An exercise 
to define dementia research priorities clarified that no na-
tion can realistically respond alone to such challenges and 
advised gaining focus to effectively reduce the burden of 
dementia [63]. 
In Portugal, we now have community prevalence 
data and (despite the scarcity of evidence regarding 
NH) the societal burden of dementia is uncontentious. 
Portuguese health services research has highlighted un-
met needs in outpatient clinics [64], problems in access 
and use of community services [65], and the unavail-
ability of information addressing people with young-
onset dementia [66]. However, we lack sustainable, fea-
sible methods to monitor trends in prevalence, 
incidence (including the conversion of minor neuro-
cognitive disorder to dementia) and survival. The same 
applies to monitoring of diagnosis, treatment, and gen-
eral management gaps. 
So, what should be done now in Portugal? What re-
search needs should be prioritized and how could they be 
efficiently met? Given all of the evidence now available, 
and ongoing work from other Portuguese groups [67], 
timely repetitions of population-based studies using a 
fixed methodology in defined catchment areas could be 
more cost-effective than larger-scale projects. For the 
moment, however, there is a much greater need for evi-
dence regarding dementia prevalence in NH, case finding 
in health and social services, and the precise care needs of 
people with dementia and their families, including early-
onset dementia. 
Specifically regarding institutions, there are barriers to 
conduction of effective research on the true dementia 
prevalence. Without adequate design and funding, we 
cannot generate meaningful estimates from a nationally 
representative sample of care homes of different types. 
One additional way to overcome these barriers is to im-
prove the robustness of sampling methods. Low partici-
pation due to incapacity to consent when legal represen-
tatives are inexistent may be addressed by exceptional 
ethical and legal approval for epidemiological assess-
ments, on justified grounds.
Characterization of health and social care delivery in 
dementia is paramount. There is Portuguese research in 
this area [65, 68–70], but improving information systems, 
e.g., through access to multisectoral data [62], is still over-
looked. Meanwhile, to avoid mismatch of resourcing with 
true needs, one should keep a critical eye on how widely 
cited estimations of people with dementia are created 
[32].
Conclusion
We updated estimates of numbers of community 
dwellers with dementia in Portugal according to the re-
sults of our previous 10/66 DRG survey. These numbers 
are remarkably higher if we use age and sex specific de-
mentia prevalence estimates according to the 10/66 DRG 
algorithm. DSM-IV dementia may represent a more spe-
cific criterion, restricting the diagnosis to more severe 
and incontrovertible cases. Both values should be consid-
ered cautiously as rough estimates, but they are consistent 
in that more than half of these people are aged 80 years or 
older. Notwithstanding the limitations of published com-
munity studies in Portugal, including our own, their find-
ings strongly support the urgent need for effective na-
tional policies in dementia care. These should include fea-
sible mechanisms to estimate dementia-related needs and 
responses periodically in health and social systems and at 
regional and national levels.
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